Ninety-four isolates of Yersinia pestis collected by the French army between 1964 and 1988 were evaluated for their susceptibilities to 24 antibiotics by the agar dilution method. All the isolates were susceptible to β-lactam antibiotics including imipenem, to fluoroquinolones, aminoglycosides and to doxycycline. The most active compounds were fluoroquinolone antibiotics, third-generation cephalosporins and aminoglycosides.
Introduction
Plague is a zoonotic disease affecting rodents. Transmission to humans occurs primarily following the bites of fleas from infected animals, and infection is usually manifested as one of the three primary forms: bubonic, septicaemic or pneumonic. Mortality for untreated bubonic plague is higher than 40%, whereas untreated septicaemic or pneumonic forms are usually fatal. Despite the efforts to control the disease, plague remains enzootic in Asia, Central-Asia, Africa, Madagascar and both in North and South America. Because of its high pathogenicity and ability to cause epidemics, Yersinia pestis has been listed among the several agents likely to be used as a biological weapon in a bioterrorism event by the Centers for Disease Control (CDC).
Streptomycin is the drug of choice for the treatment of infection in humans but is no longer available in some countries. Tetracycline and chloramphenicol have been demonstrated to be effective alternatives in humans. 1 In animal models, doxycycline, ciprofloxacin and ofloxacin have demonstrated their effectiveness, but have not been employed as first-line options for plague treatment in humans. Penicillins and cephalosporins are not effective in vivo. 2 Resistance to antibiotics is exceptional, but a high level of resistance to multiple antibiotics as a result of a self-transferable plasmid has been observed in a strain isolated from a patient with bubonic plague. 3 Another isolate, highly resistant to streptomycin has also been described. 4 Furthermore, Wong et al. published a percentage of 20.6% resistance to imipenem among 92 strains isolated over a 21-year period in the United States. 5 As described by Inglesby et al., 6 the use of an aerosolized plague weapon could cause fever, cough, chest pain and haemoptysis with signs consistent with severe pneumonia 1-6 days after exposure. Rapid evolution of disease would occur in the 2-4 days after symptom onset and would lead to septic shock with high mortality without early treatment. 6 Tetracycline, streptomycin, gentamicin and fluoroquinolone antibiotics have been recommended for post-exposure prophylaxis. 6 There is, however, a need to continue to carry out in vitro susceptibility testing to identify potential alternative agents for the treatment of plague.
Materials and methods

Security
All the experiments were conducted in the BSL3 laboratory of the Centre d'Etudes du Bouchet (Vert-le-petit, France), which is part of the French Ministry of Defence. vaccinal strain EV76 and two strains provided by the Pasteur Institute of Lille, France. Among these strains six were medievalis, six were orientalis type 1, and the other strains were orientalis type 2. Typing was done as described by Motin et al. 7 The host of origin is unknown. Antimicrobial agents were reconstituted according to manufacturers' recommendations. Susceptibility testing was done by the agar-dilution method in Mueller-Hinton medium. After identification by routine laboratory technique (Biolog system, Hayward, CA, USA), three or four colonies of each isolate were plated on blood agar and incubated for 48 h at 28°C. Colonies from plates were then suspended in PBS in order to obtain a final inoculum of 10 8 cfu/mL. One hundred microlitres was added to 3.9 mL of Mueller-Hinton broth and incubated for 24 h in a water bath at 28°C. Final inoculum was prepared before inoculation and was 10 4 cfu/spot. After inoculation, agar-plates were incubated for 48 h at 28°C. Two operators read minimal inhibitory concentrations (MICs). Quality control was Escherichia coli ATCC 25922. Interpretative criteria were done according to the Comité de l'Antibiogramme de la Société Française de Microbiologie. 8 These recommendations are freely available at http://www.sfm.asso.fr.
Bacterial strains
Susceptibility testing
Results and discussion
All the isolates tested in this protocol were susceptible to β-lactams, aminoglycosides and fluoroquinolone antibiotics (Table 1) . This result correlates well with the data previously published that demonstrated that Y. pestis isolates are usually susceptible to many antibiotics. 9 There was no difference in MICs between isolates from various geographical areas. Lower MICs were obtained with fluoroquinolone antibiotics and third-generation cephalosporins (Table 1) . Among the fluoroquinolones, the MICs of norfloxacin were higher than those observed with ofloxacin, pefloxacin and ciprofloxacin. This has been described for other Enterobacteriaceae. Gatifloxacin, a new fluoroquinolone, had the same activity as ciprofloxacin. MICs of piperacillin were equivalent to those of amoxicillin. Cefalothin and cefoxitin were effective but MICs of these antibiotics were higher than those observed with the other β-lactams.
All the isolates were susceptible to aztreonam and there was no resistant or intermediate strain to imipenem. This result is different to 5 who described 20.6% resistance among 92 strains tested in 1999. All the strains were susceptible to chloramphenicol but this antibiotic has been described as less effective in reducing mortality than standard therapy. 10 Only 30 isolates were susceptible to colistin, the others were intermediate or resistant. Among the susceptible strains 14 had MICs between 1 and 2 mg/L (breakpoint for susceptibility ≤ 2 mg/L). This result, however, is not of significant importance because this antibiotic is not used either in prophylaxis or for the treatment of plague infection and must be confirmed with Y. pestis from other collections.
In conclusion, Y. pestis remains susceptible to most antibiotics tested (except colistin) with a higher efficacy for fluoroquinolones, third-generation cephalosporins and aminoglycosides. All the strains tested were susceptible to the antibiotics recommended for postexposure prophylaxis. However, further in vivo studies are needed for determining alternative antibiotic treatments in case of bioterrorist attack with strains resistant to recommended antibiotics.
